FinVector Company
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products.
Industry:
Gene Therapy
Technology:
Others
Headquarters:
Kuopio, Eastern Finland, Finland
Estimated Revenue:
$10M to $50M